HDAC9 and cancer: Most studies on HDAC inhibitors for cancer therapy consider the inhibitory effect on a specific HDAC isoform and the in vitro antiproliferative effect against cancer cell lines (15 studies), but the cytotoxicity to normal cells, apoptosis, inhibition of migration, and in vivo studies (6 studies) are considered in fewer studies.